MétaCan
Menu
Back to cohort
Record W2804686412 · doi:10.1093/ndt/gfy104.suo015

SuO015VS-01 - A PROMISING INTRAPERITONEAL TREATMENT TO MANAGE HEPATIC ENCEPHALOPATHY AND RENAL FAILURE IN CIRRHOTIC PATIENTS

2018· article· en· W2804686412 on OpenAlexaff
Vincent Forster, Valentina Agostoni, Giovanna Giacalone, Soo Hyun Lee, Meriam Kabbaj, Cristina R. Bosoi, Mélanie Tremblay, Christopher F. Rose, Jean‐Christophe Leroux

Bibliographic record

VenueNephrology Dialysis Transplantation · 2018
Typearticle
Languageen
FieldMedicine
TopicLiver Disease and Transplantation
Canadian institutionsCentre Hospitalier de l’Université de Montréal
Fundersnot available
KeywordsMedicineHepatic encephalopathyIntensive care medicineEncephalopathyLiver failureInternal medicineGastroenterologyCirrhosis

Abstract

fetched live from OpenAlex

INTRODUCTION AND AIMS: Renal insufficiency is one of the most common and life-threatening complications of decompensated liver cirrhosis. A deterioration of the liver and kidney functions leads to metabolic imbalances that can in turn trigger other organ failures. In particular, it is often associated with hyperammonemia, the main culprit of hepatic encephalopathy (HE) potentially leading to brain failure. This syndrome called acute-on-chronic liver failure (ACLF) is associated with a high short-term mortality of 85%. The current standard of care relies on treating the precipitating factor responsible for the liver decompensation and on supportive care. Hemodialysis is routinely used in kidney-impaired patients, but can lead to hemodynamic instability. Peritoneal dialysis (PD) is emerging as the treatment of choice for patients with liver cirrhosis and end stage renal failure, but it is limited in ammonia removal which is crucial to guarantee the survival of patients with HE. METHODS: A pH-gradient liposomes suspension (VS-01) was designed for intraperitoneal infusion to enhance the clearance of ammonia and other liver and uremic toxins known to accumulate in ACLF patients. During a 3-hour dwell time, the instilled liposomes remain in the peritoneal cavity and continuously extract ammonia from the body by scavenging it into their core. Simultaneously, liver and uremic toxins are cleared by passive diffusion based on PD principles. At the end of the treatment, these vesicles and their toxic cargo are drained out of the patient. RESULTS: VS-01 is currently under preclinical development. In a rat model of secondary cirrhosis induced by bile duct ligation, VS-01 demonstrated a fast and efficient removal of ammonia, 10-fold superior to a control PD, significantly reducing the plasmatic ammonia levels and attenuating the associated brain edema. The safety of VS-01 was investigated in rats and pigs. The latter is a gold-standard model to study colloids-related hypersensitive immune reactions. The results show that VS-01 is well tolerated and does not induce any pseudoallergic reactions related to complement activation. CONCLUSIONS: These findings highlight the clinical potential of VS-01 to rapidly remove ammonia. This new, potentially lifesaving therapy for the prompt management of HE and simultaneous support of kidney and liver functions will now be investigated in clinical studies in patients with ACLF. Funding from the Swiss Commission for Technology and Innovation is acknowledged.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.007
GPT teacher head0.240
Teacher spread0.232 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueNephrology Dialysis TransplantationSame topicLiver Disease and TransplantationFrench-language works237,207